Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER_GOV × Oxaliplatin × Clear all

Phase

Status

Unknown 10 Completed 6 Recruiting 5 Not yet recruiting 5 Active not recruiting 2 Withdrawn 1 Terminated 1

Sponsor Class

OTHER 112 INDUSTRY 26 NIH 10 NETWORK 8 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Gemcitabine 4 Cisplatin 4 Rituximab 2 Fluorouracil 2 Everolimus 2 tislelizumab 1 phosphorylethanolamine 1 human papillomavirus vaccine, L1 type 16, 18 1 famitinib 1 dalpiciclib 1 Zinc Sulfate 1 Zinc 1 Vitamin B 6 1 Tamoxifen 1 Sunitinib 1 Sorafenib 1 Radiotherapy, Adjuvant 1 Pyridoxine 1 Proton Pump Inhibitors 1 Prednisone 1 Platelet Transfusion 1 Pemetrexed 1 Patient Portals 1 Paclitaxel 1 Oxaliplatin 1 Neoadjuvant Therapy 1 N-hydroxy-4-acetylaminostilbene 1 Metformin 1 Melphalan 1 Mannitol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00636883 2014-01-22

GEMOX-T

National Guard Health Affairs

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡